LUCD News and Press, Lucid Diagnostics Inc.

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...

2024-07-01 17:41:43 ET More on Lucid Diagnostics Lucid Diagnostics Inc. (LUCD) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Lucid Diagnostics Historical earnings data for Lucid Diagnostics Financial information for Lucid Diagnostics...

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing PR Newswire Firefighter #CheckYourFoodTube Precancer Testing Event organized by Mass General Brigham physicians and Boston Firefighters Local 718 IAFF NEW YORK , June...

2024-05-20 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips No matter what anyone says, the very concept of penny stocks to buy must be treated with extreme skepticism. I’m not talking about having an aggressive mistrust toward such enterpris...

PAVmed Provides Business Update and First Quarter 2024 Financial Results PR Newswire Lucid strengthens balance sheet and secures a July 17, 2024 MolDX pre-submission meeting date Veris Health completes MOU with The Ohio State's James Cancer Hospital Con...

2024-05-13 13:01:10 ET Lucid Diagnostics Inc. (LUCD) Q1 2024 Earnings Conference Call May 13, 2024 08:30 AM ET Company Participants Matt Riley - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Conference Call Participants Mike Mats...

2024-05-13 08:10:17 ET More on Lucid Diagnostics Seeking Alpha’s Quant Rating on Lucid Diagnostics Historical earnings data for Lucid Diagnostics Financial information for Lucid Diagnostics Read the full article on Seeking Alpha For further det...

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results PR Newswire Quarterly EsoGuard ® test volume increased 10 percent Strengthened balance sheet following completion of $29.8 million Series B Preferred Stock Offering ...

Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall PR Newswire EsophaCap device recalled due to recent publication of serious device failures Lucid Diagnostics' EsoCheck ® unaffected by recall and remains the gold standa...